Dr Arunachalam has recently joined ARO as a Radiation Oncologist Consultant. His specialties include lung, skin, sarcoma, as well as Stereotactic Ablative Radiotherapy, Non-malignant and Palliative cases. He is an enthusiastic, passionate and caring Radiation Oncologist who works at Auckland City Hospital. 

A clinical trial that combined stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain patients with stage 4 lung cancer, according to a new report in the Journal of Clinical Oncology 

Dr Lao presented at the Updates in Cancer Care Symposium on 15th November, held on the Mercy Hospital site.
This presentation covered the use of Stereotactic Ablative Radiation Therapy in the treatment of Lung Cancer.

Auckland Radiation Oncology selected as Australasian training site for Elekta Advanced Symmetry™4D IGRT Clinical Training Course

The concept of oligometastasis has important implications for cancer treatment because patients with limited numbers of metastasis previously thought by some clinicians to be incurable might be cured with local cancer treatments such as radiotherapy or surgery.

SBRT or SABR has demonstrated favorable rates of local control for primary and metastatic tumors and provides a treatment option for deep-seated tumors or for those who cannot undergo surgery.

Stereotactic radiotherapy can offer a short and well-tolerated treatment for lateral pelvic recurrences in previously irradiated areas in patients otherwise not treatable.

Stereotactic body radiation therapy can be an effective treatment for early stage non-small cell lung cancer

Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer

New, or progression of existing, vertebral compression fracture (VCF) post spine- stereotactic radiosurgery (SRS) for spinal metastases has been reported in the range of 10-39%. Lesion location, radiological appearance, presence of deformity, mechanical pain and percent of vertebral body involvement has reported as potential predictors of VCF. We report our pilot experience and retrospective analysis of patients thought to be at high risk of progressive VCF who were stabilized prophylactically with a percutaneous technique followed by spine SRS.